The anti-emetic and anti-nausea effect of marijuana is a centuries-old known fact. Nevertheless, as early as twenty years ago, the effect was attributed to the actions of THC. Continuous research into other cannabinoids has proven that many other phytocannabinoids produce the same desired effect. At present, the FDA recommends two drugs featuring cannabinoids, in which CBD has the highest concentration, in the treatment of nausea induced by chemotherapy – nabilone and dronabinol. Though in its infancy, promising studies exist which suggest that one day CBD may be incorporated into cancer therapies.
Numerous studies have found results that confirm the ability of marijuana to help anxiety and stress. In 2013 an Israeli study demonstrated that treatment with cannabinoids helped to control emotional responses and prevent stress-related responses for those that had experienced a traumatic experience. In 2015 a group of researchers found that cannabis treatments were effective in reducing anxiety in those suffering from PTSD.
New Drug code 7350; As a result of the financing Act and the Agriculture Act, the United States Drug Supervision Administration (DEA) clarifies the legality of the CBD. The new 7350 drug code explains that the CBD acquired from industrial cannabis is legal, by the Agriculture Act 2014. However, the CBD must be derived from legal parts of the cannabis plant, such as stems.
Then there is the matter of which part of the plant is used. THC tends to be more concentrated in the leaves of the plant, while CBD in its stem and seeds. It should be noted that these aspects are relative. Some degree of agreement exists that for the purest CBD, the stalk of a hemp plant (varieties of cannabis generally grown for fiber manufacturing, low in THC), or much less often the seeds. Taking into account the fact that CBD supplements are usually in an oil form, one may fathom the origins of the nearly ubiquitous hemp oil dietary supplements.
It all starts with the connection between the endocannabinoid system and intestinal function/motility. Recent studies have found that the transmitters regulated by the endocannabinoid system are located throughout the human body. Some of these transmitters are responsible for gut function; when imbalanced, negative effects are likely to occur. (41)